Introduces New Visian ICL(TM) Practice Building Program Launches nanoPOINT(R) Delivery System for Collamer(R) Single Piece IOL
MONROVIA, Calif., April 2, 2008 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, plans a major presence at this year's American Society of Cataract and Refractive Surgery, which will be held April 4-9, 2008 in Chicago, Illinois, it was announced here today by Barry Caldwell, President & CEO of STAAR. The Company's plans include sponsoring a certification course for refractive surgeons on the Company's Visian ICL(TM) (Implantable Collamer Lens), the full launch of its nanoPOINT delivery system, demonstrating the new NTIOL designation for the Collamer IOL and the launch of an exciting new marketing program designed to help surgeons build their Visian practice.
"Our plans at ASCRS focus on building our U.S. growth for the Visian ICL, launching our new nanoPOINT delivery system, which can inject the current STAAR Collamer Single Piece intraocular lens (IOL) through a 2.2 mm incision compared to the current requirement of a 2.8 mm to 3.0 mm incision, and capitalizing on the recent NTIOL designation for the Afinity Collamer Aspheric foldable IOL Model CQ2015A. It should be a very active and productive conference for STAAR Surgical," added Mr. Caldwell.
In addition to the certification course on the Visian ICL, STAAR will
be introducing a nine- part ICL Growth Program for refractive surgeons. The
webinar/conference call program features Dr. Brian Boxer Wachler and
focuses on the key elements required to build a successful Visian ICL
practice. Dr. Boxer Wachler has developed a very successful Visia
'/>"/>
| SOURCE STAAR Surgical Company Copyright©2008 PR Newswire. All rights reserved |